BioNTech founder suggests vaccine could lead to 'normal winter' in 2021
Ugur Sahin, the co-founder of BioNTech, warned the current winter "will be hard," but the next one could be much smoother "if everything continues to go well" with his company's coronavirus vaccine candidate.
Sahin told the BBC on Sunday that the vaccine, which is being co-developed with Pfizer and was found to be 90 percent effective in an interim trial analysis, likely won't immediately bring down infection numbers if it's unveiled later this year, but he believes "we could have a normal winter" in 2021. The plan, he said, is to deliver 300 million doses worldwide by April, which should begin to curb the spread of the virus, and after that it will be "absolutely essential" to "get a high vaccination rate before autumn/winter next year."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
